Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial

Influenza Hemagglutinin Nanoparticle Vaccine Elicits Broadly Neutralizing Antibodies against Structurally Distinct Domains of H3N2 HA

(2020) Alyse D. Portnoff et al.   Vaccines

India will supply coronavirus vaccines to the world — will its people benefit?

(2020) Gayathri Vaidyanathan   NATURE

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

(2020) Cheryl Keech et al.   NEW ENGLAND JOURNAL OF MEDICINE

Evaluation of seasonal malaria chemoprevention in two areas of intense seasonal malaria transmission: Secondary analysis of a household-randomised, placebo-controlled trial in Houndé District, Burkina Faso and Bougouni District, Mali

(2020) Matthew E. Cairns et al.   PLOS MEDICINE

RTS,S malaria vaccine pilots in three African countries

(2019) Paul Adepoju   LANCET

Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa

(2019) Yolanda Guerra Mendoza et al.   Human Vaccines & Immunotherapeutics

Long-term incidence of severe malaria following RTS,S/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomised controlled trial

(2019) Halidou Tinto et al.   LANCET INFECTIOUS DISEASES

Malaria incidence and prevalence during the first year of life in Nanoro, Burkina Faso: a birth-cohort study

(2018) Hamtandi Magloire Natama et al.   MALARIA JOURNAL

Safety and efficacy of novel malaria vaccine regimens of RTS,S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP

(2018) Tommy Rampling et al.   npj Vaccines

Changes in Malaria Epidemiology in Africa and New Challenges for Elimination

(2017) Irene N. Nkumama et al.   TRENDS IN PARASITOLOGY

Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine

(2017) Katharine A. Collins et al.   Scientific Reports

CNS infection safety signal of RTS,S/AS01 and possible association with rabies vaccine

(2016) Bradford D Gessner et al.   LANCET

Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children

(2016) Ally Olotu et al.   NEW ENGLAND JOURNAL OF MEDICINE

RTS,S Malaria Vaccine and Increased Mortality in Girls

(2016) Sabra L. Klein et al.   mBio

Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial

(2015)   LANCET

Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial

(2015) Michael T White et al.   LANCET INFECTIOUS DISEASES

Evaluation of the immune response to RTS,S/AS01 and RTS,S/AS02 adjuvanted vaccines

(2014) Geert Leroux-Roels et al.   Human Vaccines & Immunotherapeutics

Matrix-M™ adjuvant: enhancing immune responses by ‘setting the stage’ for the antigen

(2013) Karin Lövgren Bengtsson et al.   Expert Review of Vaccines

Malaria vaccine technology roadmap

(2013) Vasee S Moorthy et al.   LANCET

Immune enhancing properties of the novel Matrix-M™ adjuvant leads to potentiated immune responses to an influenza vaccine in mice

(2013) Sofia E. Magnusson et al.   VACCINE

A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

The RTS,S vaccine candidate for malaria

(2011) Jason A Regules et al.   Expert Review of Vaccines

Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care

(2011) Johan Vekemans et al.   MALARIA JOURNAL

First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children

(2011)   NEW ENGLAND JOURNAL OF MEDICINE